HuGE Literature Finder
Records
1
-
27
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study. Endocrine-related cancer 2020 7 27 (10): 541-550. Creemers S G, Feelders R A, Valdes N, Ronchi C L, Volante M, van Hemel B M, Luconi M, Ettaieb M H T, Mannelli M, Chiara M D, Fassnacht M, Papotti M, Kerstens M N, Nesi G, Haak H R, van Kemenade F J, Hofland L |
IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients. Biochemical genetics 2019 4 57 (5): 638-651. Roychowdhury Anirban, Samadder Sudip, Indra Mazumder Dipanjana, Das Pijush, Basu Mukta, Mondal Ranajit, Roy Anup, Roychoudhury Susanta, Panda Chinmay Kum |
Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification. Disease markers 2018 10 2018 8635329. Li Cheng-Wei, Chiu Yu-Kai, Chen Bor-S |
Epigenetic alterations of the Igf2 promoter and the effect of miR?483?5p on its target gene expression in esophageal squamous cell carcinoma. Molecular medicine reports 2017 12 17 (2): 2251-2256. Zhang Han, Shi Xiaowei, Chang Weidong, Li Yingying, Wang Li, Wang Linso |
Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4. Cell communication and signaling : CCS 2017 10 15 (1): 40. Schagdarsurengin Undraga, Lammert Angela, Schunk Natalie, Sheridan Diana, Gattenloehner Stefan, Steger Klaus, Wagenlehner Florian, Dansranjavin Temuuj |
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas. Endocrine-related cancer 2016 8 23 (9): 727-37. Creemers S G, van Koetsveld P M, van Kemenade F J, Papathomas T G, Franssen G J H, Dogan F, Eekhoff E M W, van der Valk P, de Herder W W, Janssen J A M J L, Feelders R A, Hofland L |
Breast cancer risk and imprinting methylation in blood. Clinical epigenetics 2015 9 7 (1): 92. Harrison Kristina, Hoad Gwen, Scott Paula, Simpson Louise, Horgan Graham W, Smyth Elizabeth, Heys Steven D, Haggarty Pa |
Genomic landscape of paediatric adrenocortical tumours. Nature communications 2015 6 6302. Pinto Emilia M, Chen Xiang, Easton John, Finkelstein David, Liu Zhifa, Pounds Stanley, Rodriguez-Galindo Carlos, Lund Troy C, Mardis Elaine R, Wilson Richard K, Boggs Kristy, Yergeau Donald, Cheng Jinjun, Mulder Heather L, Manne Jayanthi, Jenkins Jesse, Mastellaro Maria J, Figueiredo Bonald C, Dyer Michael A, Pappo Alberto, Zhang Jinghui, Downing James R, Ribeiro Raul C, Zambetti Gerard |
Targeted deep DNA methylation analysis of circulating cell-free DNA in plasma using massively parallel semiconductor sequencing. Epigenomics 2015 6 7 (3): 353-62. Vaca-Paniagua Felipe, Oliver Javier, Nogueira da Costa Andre, Merle Philippe, McKay James, Herceg Zdenko, Holmila Reet |
Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma. Tissue antigens 2014 Sep 84 (3): 264-70. Xie H-Y, Xing C-Y, Wei B-J, Xu X, Wu J, Chen L-M, Cao G-Q, Chen H, Chen K-J, Yin S-Y, Wu L-M, Zhou L, Zheng S |
Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. The American journal of clinical nutrition 2014 11 100 (6): 1479-88. Nishihara Reiko, Wang Molin, Qian Zhi Rong, Baba Yoshifumi, Yamauchi Mai, Mima Kosuke, Sukawa Yasutaka, Kim Sun A, Inamura Kentaro, Zhang Xuehong, Wu Kana, Giovannucci Edward L, Chan Andrew T, Fuchs Charles S, Ogino Shuji, Schernhammer Eva |
Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 2014 1 35 (2): 608-19. Tang Shaohui, Hu Wei, Hu Jianjun, Wu Shenglan, Li Junfeng, Luo Yuhong, Cao Mingrong, Zhou Hongke, Jiang Xiang |
Role of polymorphisms of the IGF2 and IGFBP3 genes and risk of gastric carcinoma in China. Chinese medical journal 2014 127 (3): 412-6. Gu Jun, Li Maolan, Dong Ping, Lu Jianhua, Tan Zhujun, Wu Xiangsong, Mu Jiasheng, Zhang Lin, Wu Wenguang, Ding Qichen, Yang Jiahua, Cao Yang, Ding Qian, Weng Hao, Liu Yingb |
Increased Intragenic IGF2 Methylation is Associated with Repression of Insulator Activity and Elevated Expression in Serous Ovarian Carcinoma. Frontiers in oncology 2013 6 3 131. Huang Zhiqing, Murphy Susan |
Association between Gly1619ARG polymorphism of IGF2R domain 11 (rs629849) and advanced stage of oral cancer. Medical oncology (Northwood, London, England) 2012 Jun 29 (2): 682-5. Yoon Angela J, Zavras Athanasios I, Chen Mu-Kuan, Lin Chiao-Wen, Yang Shun- |
Promoter CpG island hypermethylation during breast cancer progression. Virchows Archiv : an international journal of pathology 2010 12 458 (1): 73-84. Park So Yeon, Kwon Hyeong Ju, Lee Hee Eun, Ryu Han Suk, Kim Sung-Won, Kim Jee Hyun, Kim In Ah, Jung Namhee, Cho Nam-Yun, Kang Gyeong Ho |
Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 2010 11 60 (4): 499-508. Ibrahim Ashraf E K, Arends Mark J, Silva Ana-Luisa, Wyllie Andrew H, Greger Liliana, Ito Yoko, Vowler Sarah L, Huang Tim H-M, Tavaré Simon, Murrell Adele, Brenton James |
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. International journal of cancer. Journal international du cancer 2009 Dec 125 (11): 2673-8. Hoyo Cathrine, Schildkraut Joellen M, Murphy Susan K, Chow Wong-Ho, Vaughan Thomas L, Risch Harvey, Marks Jeffrey R, Jirtle Randy L, Calingaert Brian, Calingeart Brian, Mayne Susan, Fraumeni Joseph, Gammon Marilie |
Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia. International journal of oncology 2009 6 35 (1): 87-96. Paradowska Agnieszka, Fenic Irina, Konrad Lutz, Sturm Klaus, Wagenlehner Florian, Weidner Wolfgang, Steger Kla |
Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma. International journal of oncology 2009 12 36 (1): 171-9. Dammann Reinhard H, Kirsch Sebastian, Schagdarsurengin Undraga, Dansranjavin Temuujin, Gradhand Elise, Schmitt Wolfgang D, Hauptmann Steff |
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Archiv : an international journal of pathology 2007 3 450 (5): 529-37. Ogino Shuji, Meyerhardt Jeffrey A, Kawasaki Takako, Clark Jeffrey W, Ryan David P, Kulke Matthew H, Enzinger Peter C, Wolpin Brian M, Loda Massimo, Fuchs Charles |
DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Laboratory investigation; a journal of technical methods and pathology 2007 12 88 (2): 161-70. Kang Gyeong Hoon, Lee Sun, Cho Nam-Yun, Gandamihardja Tasha, Long Tiffany I, Weisenberger Daniel J, Campan Mihaela, Laird Peter |
Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools. The Journal of molecular diagnostics : JMD 2007 8 9 (4): 510-20. Dejeux Emelyne, Audard Virginie, Cavard Catherine, Gut Ivo Glynne, Terris Benoit, Tost Jö |
IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochemical and biophysical research communications 2006 Jul 346 (1): 38-44. Kim Yoon Jun, Yoon Jung-Hwan, Kim Chung Yong, Kim Lyoung Hyo, Park Byung Lae, Shin Hyoung Doo, Lee Hyo-S |
H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis. International journal of molecular medicine 2006 1 17 (2): 397-404. De Castro Valente Esteves Leda Isabel, De Karla Cervigne Nilva, Do Carmo Javaroni Afonso, Magrin José, Kowalski Luiz Paulo, Rainho Cláudia Aparecida, Rogatto Silvia Regi |
DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas? Molecular carcinogenesis 2005 7 44 (2): 102-10. Esteves Leda I C V, Javaroni Afonso C, Nishimoto Inês N, Magrin José, Squire Jeremy A, Kowalski Luiz P, Rainho Cláudia A, Rogatto Silvia |
Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma. The Journal of pathology 2003 11 201 (3): 473-9. Poirier Karine, Chalas Céline, Tissier Frédérique, Couvert Philippe, Mallet Vincent, Carrié Alain, Marchio Agnès, Sarli Dario, Gicquel Christine, Chaussade Stanislas, Beljord Cherif, Chelly Jamel, Kerjean Antoine, Terris Beno |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: